Patents
Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
04/2006
04/19/2006EP1370559B1 Triazolopyridines as anti-inflammatory agents
04/19/2006EP1349833B1 Indole and dihydroindole derivatives
04/19/2006EP1339407B1 Farnesyl protein transferase inhibitors for the treatment of inflammatory bowel disease
04/19/2006EP1296959B1 Methods and compositions utilizing quinazolinones
04/19/2006EP1296692B1 Use of a formulation made of or containing at least one dissimilated milk serum
04/19/2006EP1294724B1 Pyrrolo¬2,3-d|pyrimidine compounds as immunosuppressive agents
04/19/2006EP1259125B1 Inulin products with improved nutritional properties
04/19/2006EP1255452B1 A method for maintaining or improving the synthesis of mucins
04/19/2006EP1237886B1 Meglumine salt of a specific quinolinecarboxylic acid compound active on nmda receptors
04/19/2006EP1227820B1 Oligosaccharide aldonic acids and their topical use
04/19/2006EP1143940B1 Compositions and methods for mucosal delivery
04/19/2006EP1143806B1 Method for increasing pet activity
04/19/2006EP1107772B1 Composition with bacillus coagulans and use thereof
04/19/2006EP1080726B1 Agents for relieving side effects
04/19/2006EP0901474B1 Aryl pyrimidine derivatives
04/19/2006EP0885215B1 Novel benzo-1,3-dioxolyl- and benzofuranyl substituted pyrrolidine derivatives as endothelin antagonists
04/19/2006CN1761680A Metastin derivative and use thereof
04/19/2006CN1761481A Osteogenic composition
04/19/2006CN1761474A Actacid composition
04/19/2006CN1761472A Regulation of cell surface proteins
04/19/2006CN1761470A Combination of a macrolide t-cell immunomodulator and a calciferol for the treatment of skin diseases or of inflammatory bowel disease
04/19/2006CN1761460A Antiflatulents in combination with histamine H1-receptor antagonists for treating gastrointestinal disorders
04/19/2006CN1759884A Chinese traditional medicine prescription for treating hepatitis B and preparation technics
04/19/2006CN1759875A Method for fabricating preparation for treating disease of digestion
04/19/2006CN1759872A Powder of Chinese traditional medicine 'Ganfukang' for treating liver disease
04/19/2006CN1759870A Chinese traditional medicine preparation for treating intestinal tract disease
04/19/2006CN1759866A Method for preparing Chinese herbal medicine of treating gastric ulcer
04/19/2006CN1759862A Prescription of arenobufagin drop pills and preparation method
04/19/2006CN1759859A Medication of Hance Brandisia Herb for treating virus hepatitis
04/19/2006CN1759855A Medication for treating chronic hepatitis
04/19/2006CN1759852A Prescription of epimedium drop pills, an dpreparation method
04/19/2006CN1759845A Series of recipe of alive liver cell element, and application
04/19/2006CN1759835A Dextrose translusion of fibrauretime, and preparation method
04/19/2006CN1759827A Recipe of drop pills of diisopropylamine dichloroacetate, and preparation method
04/19/2006CN1759826A Coating method for microcapsule of lysine hydrochloride
04/19/2006CN1252239C Wine of twin ginseng and preparation method
04/19/2006CN1252088C Deer serum active polypeptide crystal preparation and its preparing method
04/19/2006CN1252071C Xanthine Phosphodiesterase V inhibitors
04/19/2006CN1252070C Urea substituted imidazoquinolines
04/19/2006CN1252067C Benzazole derivatives and their use as JNK modulators
04/19/2006CN1252040C Novel aryl, alkenyl and alkynl 4-dedimethylamino tetracycline derivatives
04/19/2006CN1251752C Chinese medicine for treating hepatitis B and preparing method thereof
04/19/2006CN1251751C Chinese traditional medicine for treating chronic liver disease and anti hepatic fibrosis and its prepn. process
04/19/2006CN1251745C Medicine for treating liver and biliary diseases and its preparing method
04/19/2006CN1251743C Prescription for treating duodenal ulcer and gastric ulcer
04/19/2006CN1251737C Chinese traditional medicine capsule for treating hepatitis
04/19/2006CN1251734C Sobering and liver protecting liquid product and its production method
04/19/2006CN1251733C Preparation of enhanced agastache capsules
04/19/2006CN1251714C Medicine for treating acute and chronic hepatitis
04/19/2006CN1251712C Chinese medicine composition for treating hepatitis and its preparing method
04/19/2006CN1251709C Health care capsule for middle aged woman
04/19/2006CN1251700C Application of flatstem milkvetch seed and its extract in the preparation of anti hepatic fibrosis medicine and anticancer medicine
04/19/2006CN1251694C Chinese medicine formulation for treating upper respiratory system disease, skin infection and haemorr hoids and its preparing method
04/19/2006CN1251687C Medicinal composition for treationg virus infention of rlavivirus family, set group and packaged products
04/19/2006CN1251686C Safety quick effective rectal suppository
04/19/2006CN1251682C Medicine for treating infantile enterorrhea
04/19/2006CN1251676C Phenyl xanthine derivative
04/18/2006US7030242 Selective inhibition of aggrecanase in osteoarthritis treatment
04/18/2006US7030160 An agonist as beta-3 adrenergic receptors; chemical intermediates preparing through decyclization, hydroxylation; for treating gastrointestinal diseases, obesity, diabetics, psychotropic agents, nervous system disorders
04/18/2006US7030147 Synergistic mixture; antiproliferative agents; side effect reduction
04/18/2006US7030128 Imidazo-pyrimidine derivatives as ligands for GABA receptors
04/18/2006US7030107 nitrogen compounds such as 5-[3,5-bis(trifluoromethyl)benzyl]-6-oxo-7-phenyl-9-[4-(pyrrolidine-1-yl)piperidine-1-yl]-2,3,4,5-tetrahydro-6H-pyrido[2,3-b][1,5]oxazocine, used as neurokinin inhibitors for prophylaxis of urogenital disorders; side effect reduction
04/18/2006US7030090 Immune-modulating peptide
04/18/2006US7030089 Use of substituted acryloyl distamycin derivatives in the treatment of tumors associated with high levels of glutathione
04/18/2006US7029914 DNA encoding SNORF36 receptors
04/18/2006US7029877 binding protease thrombin to phosphoethanolamine binding protein
04/18/2006US7029713 Peptide extract of lupine and pharmaceutical or cosmetic or nutritional composition comprising the same
04/18/2006US7029670 Medicines for relieving intestinal disorders
04/18/2006US7029669 pure culture of Lactobacillus paracasei CNCM I-2116 that adheres to and colonizes intestinal mucosa and preventis infection of intestinal epithelial cells by rotaviruses; may be mixed with foods such as milk, yogurt, cheese, ice cream, fermented cereal based products and infant formula
04/18/2006CA2346335C Sertraline oral concentrate
04/13/2006WO2006038738A1 Receptor function regulating agent
04/13/2006WO2006038721A1 External preparation
04/13/2006WO2006038680A1 2-arylcarboxamide-nitrogeneous heterocycle compound
04/13/2006WO2006038608A1 Oligo double-stranded rna and medicinal composition
04/13/2006WO2006038596A1 Pharmaceutical composition for xerophthalmia and xerostomia treatment
04/13/2006WO2006037848A1 Method and preparation for binding aldehydes in saliva
04/13/2006WO2006037766A1 Oral pharmaceutical preparation comprising a proton pump antagonist and a basic excipient
04/13/2006WO2006037748A1 Substituted tricyclic benzimidazoles
04/13/2006WO2006037481A1 Benzoxazine and quinoxaline derivatives and uses
04/13/2006WO2006018185A3 Dihydropteridinones for the treatment of cancer diseases
04/13/2006US20060079707 Cyclization by reacting 4-(2-CHLORO-4-TRIFLUOROMETHYL-PHENYL)-4-CYANO-BUT-3-ENOIC ACID METHYL ESTER in the presence of a palladium catalyst and a base; chemical intermediates for preparing 10-AZA-TRICYCLO[6.3.1.02,7] drugs; bind nicotinic acetylcholine receptor, modulate cholinergic function
04/13/2006US20060079688 Process for producing acid adduct salt of polyacidic base compound
04/13/2006US20060079670 98 human secreted proteins
04/13/2006US20060079563 Cyclic protein tyrosine kinase inhibitors
04/13/2006US20060079560 Crystalline form of omeprazole
04/13/2006US20060079548 Benzofused heterozryl amide derivatives of thienopyridines useful as therapeutic agents, pharmaceutical compositions including the same, and methods for their use
04/13/2006US20060079545 Palonosetron for the treatment of chemotherapy induced emeses
04/13/2006US20060079525 antiinflammatory agent N-{[(2S)-4-(3,4-dichlorobenzyl)morpholin-2-yl]methyl}cyclopropane carboxamide; bronchitis, asthma, chronic obstructive pulmonary disease and rhinitis
04/13/2006US20060079503 Thiazolidinones and the use therof as polo-like kinase inhibitors
04/13/2006US20060079502 Pharmaceutical compositions
04/13/2006US20060079488 Methods of treating and preventing bone loss
04/13/2006US20060078989 Dedifferentiated, programmable stem cells of monocytic origin, and their production and use
04/13/2006US20060078918 Detecting the activity of orphan G Protein Receptor 86 by incubating a sample comprising GPR86 and adenosine diphosphate (ADP) under binding conditions for both and detecting a second messanger; screening for a modulator
04/13/2006US20060078879 Polymorphisms in the human gene for tpmt and their use in diagnostic and therapeutic applications
04/13/2006US20060078620 Oil composition based on peroxidised lipids, which can be used in the treatment of xerostomia
04/13/2006US20060078595 Use of glutamate and/or a glutamate precursor for the preparation of a nutritional or pharmaceutical preparation for the treatment or prevention of hyperpermeability or undesired permeability of the intestinal wall
04/13/2006US20060078547 Lactobacillus salivarius strain, AH102, AH103, AH105, AH109 or AH110 or mutants or variants are useful in the prophylaxis and/or treatment undesirable gastrointestinal inflammatory activity, such as inflammatory bowel disease or irritable bowel syndrome
04/13/2006DE10394216T5 Hepatoprotektive pharmazeutische Zusammensetzung umfassend eine Mischung aus Coumarinlignoiden und Verfahren zur Herstellung derselben Hepatoprotective pharmaceutical composition comprising a mixture of coumarinolignoids and methods for making the same
04/13/2006DE102004052308A1 Octenidinhaltige Lutschtabletten gegen entzündliche Erkrankungen des Mund- und Rachenraums Octenidine lozenges against inflammatory diseases of the mouth and throat
04/13/2006DE102004048877A1 New tricyclic thiazole derivatives useful as PI3 kinase inhibitors, for treating e.g. inflammatory and allergic airway and skin diseases, autoimmune and kidney disease